May 27, 2025 C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is
May 22, 2025 RDCA-DAP and NORD’s IAMRARE Platform to Platform Federation: Lessons Learned Patient data is a key asset in understanding the progression of rare diseases...
April 11, 2025 C-Path Launches Newest Podcast Episode: Connecting the Dots Between T1D and Parkinson’s In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...
March 27, 2025 From Musician to Physician to Clinical Scientist: C-Path CEO Klaus Romero Shares His Journey During National Physicians Week Every year, National Physicians Week is celebrated from March 25-31, a time to honor the dedication and resilience of our...
March 25, 2025 Breaking Down Research: Investigation of Urinary miRNAs for Early Detection of Kidney Damage in selected lab animals Drug-induced kidney injury is commonly identified during drug development and serves as a dose-limiting factor...
March 21, 2025 The Critical Path Institute Podcast: Connecting the Dots with COA VP Dr. Cheryl Coon If you have attended one of C-Path’s stakeholder meetings, read one of our impact stories or engaged through our social...
April 17, 2025 RDCA-DAP Webinar: ACE Inhibitors as a Cardioprotective Treatment in Dystrophinopathies ACE inhibitors were the first pharmacological class shown to benefit heart failure treatment...
February 24, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series – Session #1: Setting the Scene C-Path's CPLD team presents, "Lysosomal Storage Disease Data Sharing Workshop, Webinar Series - Session #1...
February 19, 2025 Advancing Neonatal Drug Development Through Collaboration At C-Path’s INC, we believe that meaningful progress in neonatal drug development...
January 7, 2025 Inclusion in neurological research: empowering people living with neurological diseases The value of involving people living with diseases in the research process is increasingly recognized...
